Trimeris News
Most Popular Trimeris Story
Struggling Trimeris gets snapped up for $81M
The struggling Durham, NC-based Trimeris is being snapped up by South Korea's Arigene for $81 million in cash. Both boards have approved the deal. Trimeris' shares (TRMS) had traded at about $30 back... Read more...
Latest Headlines
- October 5, 2009
- May 12, 2008
- December 11, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
